Literature DB >> 16810432

Referral patterns and waiting times for liver transplantation in Singapore.

S G Lim1, C T Wai, M Da Costa, D S Sutedja, Y M Lee, K H Lee, C K Tan, M M Aw, S H Quak, K Prabhakaran, K C Tan, J Isaac.   

Abstract

INTRODUCTION: Referral patterns, waiting times, waiting list, and mortality provide information on how effectively a transplant programme deals with referred patients. This paper aims to review these parameters in the Singapore National Liver Transplant Programme.
METHODS: Data of all patients referred to the Singapore National Liver Transplant Programme since its inception were captured and outcomes were retrieved and described.
RESULTS: 562 patients were referred for liver transplant evaluation from 1990-2004, consisting of 457 adults and 105 children. The main indications for referral were hepatitis B liver disease and hepatocellular carcinoma in adults, and biliary atresia in children. Most patients were of United Network of Organ Sharing (UNOS) status 3 or 4 at the time of referral. 114 (20.28 percent) patients had transplants, consisting of 66 adults (14.44 percent) and 48 (45.71 percent) children. 138 adults and ten children were rejected for transplant, mainly for the reason of being "too early". The median waiting time for adults who had transplants was 3.3 months while adults still on the waiting list had been waiting for 16.2 months. The overall waiting list mortality was 44.3 percent, being 52.5 percent in adults and 23.2 percent in children.
CONCLUSION: The overall transplantation rate is low and the waiting list mortality is high as a result of low availability of organs, particularly in adults. Paediatric liver transplant appears to have been better at dealing with referred patients but this is probably due to availability of living-related liver transplant. Improvement in these may result from the Human Organ Transplant Act.

Entities:  

Mesh:

Year:  2006        PMID: 16810432

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

Review 1.  Methods to decrease blood loss and transfusion requirements for liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Theodora Pissanou; Hynek Pikhart; Jessica Vaughan; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Authors:  Chuan Li; Kai Mi; Tian fu Wen; Lu nan Yan; Bo Li; Jia ying Yang; Ming qing Xu; Wen tao Wang; Yong gang Wei
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

3.  Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?

Authors:  Chun Han Nigel Tan; Yue Yu; Yan Rui Nicholas Tan; Boon Leng Kieron Lim; Shridhar Ganpathi Iyer; Krishnakumar Madhavan; Alfred Wei Chieh Kow
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

Review 4.  Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Brian R Davidson; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2013-12-02

Review 5.  Ischaemic preconditioning for liver transplantation.

Authors:  K S Gurusamy; Y Kumar; D Sharma; B R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 6.  Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Elias Xirouchakis; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.